SALMETEROL/FLUTICASONPROPIONAT Devatis 250 µg DA

7680699030026 CH-69903 R03AK06 03.04.3.

Active substances:

Salmeterolum

No images available

Details

Product number
6990302
CPT
-
Packaging group
120
Unit
Einzeldose(n)
Composition
salmeterolum 25 µg ut salmeteroli xinafoas, fluticasoni propionas 250 µg, norfluranum ad aerosolum pro dosi, doses pro vase 120.

Articles (1)

Salmeterol/Fluticasonpropionat Devatis 25 μg/250 μg, Dosier-Aerosol
Dosier-Aerosol
120
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/10/2025
Patient information leaflet
Français
27/10/2025
Patient information leaflet
Italien
27/10/2025
Professional SmPC
Italien
27/10/2025
Professional SmPC
Allemand
27/10/2025
Professional SmPC
Français
27/10/2025

Detailed composition

Substance Quantity Type Category
salmeterolum
25.0 UG Substance Wirkstoff (Principe actif)
salmeteroli xinafoas
- Substance WIZUS
fluticasoni propionas
250.0 UG Substance Wirkstoff (Principe actif)
norfluranum
- Substance HFKW

Authorization holder

Devatis AG

6330 Cham

Authorization information

Swissmedic authorization number
69903
Drug name
Salmeterol/Fluticasonpropionat Devatis, Dosier-Aeroseol
Galenic form
GASDS
ATC Code
R03AK06
Authorization status
Z
Dispensation category
B
First authorization
16/09/2025
Authorization expiration date
15/09/2030
IT number
03.04.3.
Domain
Human medicine
Field of application
Asthma

Packaging details

Description (FR)
SALMETEROL/FLUTICASONPROPIONAT Devatis 250 µg DA
Description (DE)
SALMETEROL/FLUTICASONPROPIONAT Devatis 250 µg DA
Market launch
01/12/2025
Narcotic (BTM)
No

Other packaging sizes

SALMETEROL/FLUTICASONPROPIONAT Devatis 125µg DA
120 EINZ
GTIN: 7680699030019
View
Buy us a coffee Explore the data